Effects of lubiprostone withdrawal on symptoms and recurrence in patients with constipation-predominant irritable bowel syndrome
Phase of Trial: Phase III
Latest Information Update: 10 May 2011
At a glance
- Drugs Lubiprostone (Primary)
- Indications Irritable bowel syndrome
- Focus Therapeutic Use
- Sponsors Sucampo Pharmaceuticals
- 10 May 2011 Results presented at the Digestive Disease Week 2011.
- 05 Nov 2010 New trial record.